New AI technology may aid in the discovery of therapeutic agents for neurodegenerative disorders

A research group from Nagoya University in Japan has developed an artificial intelligence for analyzing cell images that uses machine learning to predict the therapeutic effect of drugs.

Related Keywords

Nagoya ,Aichi ,Japan ,Masahisa Katsuno ,Madoka Iida ,Ryuji Kato ,Emily Henderson ,Kei Kanie ,Nagoya University Nu Cross ,Nagoya University ,School Of Medicine ,School Of Pharmaceutical Sciences ,Associate Professor Ryuji Kato ,Assistant Professor Kei Kanie ,Graduate School ,Pharmaceutical Sciences ,Professor Masahisa Katsuno ,Assistant Professor Madoka Iida ,Associate Professor ,Departmental Innovation Creation ,Drugs ,Eurodegenerative Disease ,Euron ,Artificial Intelligence ,Fell ,Efficacy ,Kennedy Disease ,Machine Learning ,Neurodegenerative Diseases ,Eurons ,Research ,